This study tests whether giving young children monthly malaria prevention medicine (dihydroartemisinin-piperaquine) from 8 weeks old up to 1 or 2 years of age can help their bodies build stronger immunity against malaria. About 924 children in Uganda will be followed until age 4 …
Phase: PHASE3 • Sponsor: Grant Dorsey, M.D, Ph.D. • Aim: Disease control
Last updated Apr 26, 2026 19:39 UTC